News Snapshot:
During global scrambling to secure vaccines, many countries in the Asia-Pacific region failed to meet their goals. This time they haven’t made the same mistake. Countries in the region are rushing to order the latest weapons for Covid-19. This is an antiviral drug that has not yet been approved for use. Molnupiravir, manufactured by US pharmaceutical company Merck, is said to have the potential to become a pandemic game changer, especially for those who are not vaccinated. Merck is seeking an emergency use authorization for this drug from the US Food and Drug Administration. If permitted, the capsule will be...
